Apellis Pharmaceuticals Inc [APLS] Records 200-Day SMA of $51.63
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals Inc shares valued at $3,743,605 were sold by Deschatelets Pascal on Apr 08 ’24. At $54.17 per share, Deschatelets Pascal sold 69,107 shares. The insider’s holdings dropped to 1,115,983 shares worth approximately $53.49 million following […]
Apellis Pharmaceuticals Inc [APLS] Deschatelets Pascal sells 69,107 Shares for $3.74 million
Apellis Pharmaceuticals Inc’s recent filing unveils that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million on Apr 08 ’24. In the deal valued at $54.17 per share,69,107 shares were sold. As a result of this transaction, Deschatelets Pascal now holds 1,115,983 shares worth roughly $53.17 million. Then, Sullivan Timothy Eugene […]
Apellis Pharmaceuticals Inc [APLS] Chief Scientific Officer makes an insider purchase of 69,107 shares worth 3.74 million.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals Inc shares valued at $3,743,605 were sold by Deschatelets Pascal on Apr 08 ’24. At $54.17 per share, Deschatelets Pascal sold 69,107 shares. The insider’s holdings dropped to 1,115,983 shares worth approximately $53.02 million following […]
Apellis Pharmaceuticals Inc’s latest rating changes from various analysts
Apellis Pharmaceuticals Inc’s filing revealed that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million on Apr 08 ’24. In the deal valued at $54.17 per share,69,107 shares were sold. As a result of this transaction, Deschatelets Pascal now holds 1,115,983 shares worth roughly $57.47 million. Then, Sullivan Timothy Eugene sold […]
APLS Stock Sees Decline of Approximately -0.57% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Apellis Pharmaceuticals Inc shares valued at $3,743,605 were sold by Deschatelets Pascal on Apr 08 ’24. At $54.17 per share, Deschatelets Pascal sold 69,107 shares. The insider’s holdings dropped to 1,115,983 […]
Apellis Pharmaceuticals Inc [APLS] Insider Selling: Time to sell?
Apellis Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Sullivan Timothy Eugene unloaded Company’s shares for reported $0.23 million on Apr 01 ’24. In the deal valued at $58.66 per share,4,000 shares were sold. As a result of this transaction, Sullivan Timothy Eugene now holds 93,338 shares worth roughly $5.02 million. Then, Dunlop […]
Apellis Pharmaceuticals Inc [APLS] Records 50-Day SMA of $62.74
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals Inc shares valued at $234,640 were sold by Sullivan Timothy Eugene on Apr 01 ’24. At $58.66 per share, Sullivan Timothy Eugene sold 4,000 shares. The insider’s holdings dropped to 93,338 shares worth approximately $5.23 […]
Apellis Pharmaceuticals Inc [APLS] Insider Dunlop A. Sinclair sells 18,681 Shares
Apellis Pharmaceuticals Inc’s recently made public that its Director Dunlop A. Sinclair unloaded Company’s shares for reported $1.07 million on Mar 19 ’24. In the deal valued at $57.18 per share,18,681 shares were sold. As a result of this transaction, Dunlop A. Sinclair now holds 173,998 shares worth roughly $10.39 million. Then, DeLong Mark Jeffrey […]
Selling Buzz: Apellis Pharmaceuticals Inc [APLS] Director Dunlop A. Sinclair sells 18,681 shares of the company
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Apellis Pharmaceuticals Inc shares valued at $1,068,161 were sold by Dunlop A. Sinclair on Mar 19 ’24. At $57.18 per share, Dunlop A. Sinclair sold 18,681 shares. The insider’s holdings dropped to 173,998 shares […]
Jefferies upgrades Apellis Pharmaceuticals Inc (APLS) rating to a Buy
Apellis Pharmaceuticals Inc’s recently made public that its Director Dunlop A. Sinclair unloaded Company’s shares for reported $1.07 million on Mar 19 ’24. In the deal valued at $57.18 per share,18,681 shares were sold. As a result of this transaction, Dunlop A. Sinclair now holds 173,998 shares worth roughly $9.64 million. Then, DeLong Mark Jeffrey […]
